FGF23 affects mortality, CV risk in type 2 diabetes with mildly impaired kidney function



There is an association between higher levels of fibroblast growth factor 23, or FGF23, and greater cardiovascular and mortality risks for adults with type 2 diabetes and normal or mildly impaired kidney function, according to findings published in Diabetes Care.
“So far, most studies had focused on the role of FGF23 in patients with reduced kidney function,” Martin H. de Borst, MD, PhD, a consultant nephrologist, adjunct professor of medicine at the University of Groningen and University Medical Center in the Netherlands, and Stanley M.H. Yeung, of the division of nephrology in



Source link

Leave a Reply!

So glad to see you sticking around!

Want to be the first one to receive the new stuff?

Enter your email address below and we'll send you the goodies straight to your inbox.

Thank You For Subscribing!

This means the world to me!

Spamming is not included! Pinky promise.